Circumvallate Placenta: Associated Clinical Manifestations and Complications—A Retrospective Study

Table 3

Comparison of unadjusted and adjusted neonatal outcomes between circumvallate placenta and control groups.

	Control	Circumvallate placenta OR (95% CI)	value
SGA
Unadjusted	1	4.64 (3.02–7.12)	<0.01
Adjusted^*	1	2.50 (1.58–3.95)	<0.01
UA pH < 7.10
Unadjusted	1	4.65 (2.22–9.73)	<0.01
Adjusted^*	1	0	0.81
NICU admission
Unadjusted	1	8.68 (5.69–13.2)	<0.01
Adjusted^*	1	0.50 (0.19–1.30)	0.16
Chronic lung disease
Unadjusted	1	27.2 (15.9–46.6)	<0.01
Adjusted^*	1	2.92 (1.30–6.56)	<0.01
Neonatal death
Unadjusted	1	32.6 (14.4–74.0)	<0.01
Adjusted^*	1	2.70 (1.03–7.10)	<0.05

SGA: small-for-gestational age; UA pH: umbilical artery pH; NICU: neonatal intensive care unit; SE: standard error; OR: odds ratio.
^*Adjusted by gestational weeks at delivery.